Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Jack Rayfield who wrote (4773)	11/8/1999 4:26:00 PM
From: Jack Rayfield	Read Replies (1) \| Respond to of 8117

Pyng Medical Corp. Announces Growing Body of Clinical Data on the F.A.S.T.1 System for Adult Intraosseous Infusion VANCOUVER, British Columbia--(BUSINESS WIRE)--Nov. 8, 1999--Pyng Tech.(VSE:PYT. - news; OTC Bulletin Board:PYNGF - news) Pyng Medical Corp. (subsidiary of Pyng Technologies Corp.) learned this week that a key multi services study on the F.A.S.T.1 System for Adult Intraosseous Infusion involving hospitals or EMS services in British Columbia, Arizona, Virginia, Missouri, Maryland and New York was accepted for publication by the peer reviewed journal ``Prehospital Emergency Care'. The publication date is planned for early 2000 and should, coincidentally, be released at a similar time to the commercial release of the F.A.S.T. 1 System. In addition presentations were also made in late October at major U.S. and Canadian medical congresses for Emergency Medical Service (EMS) personnel and Emergency Physicians, on the ability of the F.A.S.T.1 System for Adult Intraosseous Infusion to gain rapid central vascular access in shock and trauma patients. Clinical papers were presented at the American College of Emergency Physicians meeting in Las Vegas involving the F.A.S.T. 1 System. Dr. Brian Tiffany and other medical professionals at Arizona Heart Hospital and Maricopa Medical Center in Phoenix concluded that ``The F.A.S.T. 1 is a safe and effective means of gaining rapid intravenous access in cardiac arrest patients where conventional access is unsuccessful or too time consuming'. In an additional paper, Dr. Bruce Horwood et al Maricopa / Rural Metro in Arizona reported on their experience using the F.A.S.T. 1 System in the prehospital, paramedic setting and reached similar conclusions regarding the ability to achieve rapid central vascular access with the F.A.S.T.1 System. Also in October, Dr. Eric Grafstein of St. Paul's Hospital Emergency Department reported on his ability to gain rapid access using the F.A.S.T. 1 System at the Canadian Association of Emergency Physicians Meeting in Quebec City, Canada. Commenting on the clinical developments Michael W. Jacobs, President of Pyng Technologies Corp. and Pyng Medical Corp. states that ``We are delighted that a growing clinical awareness of our life saving technology has confirmed what we have seen in our own R&D studies. Clinical reports on the effectiveness of the F.A.S.T. 1 are very important to the advancement of the System in the emergency medical marketplace.' Pyng Technologies is the world leader in the development of Adult Intraosseous Infusion in the sternal site. The F.A.S.T. 1 System is a patented, life saving technology for the infusion of volume replacement fluids and medications with applications in emergency response, hospital and military markets. The F.A.S.T. 1 System has been cleared for marketing in the United States by the FDA and in Canada by the Health Protection Branch. The System has received Military stocking numbers for both NATO and the US. The VSE has neither reviewed or approved of the contents of this news release.